Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV vaccination immune response and safety in girls with autoimmune disease
NL-OMON40068Phase 4Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of human papillomavirus vaccine in human papillomavirus infection and Cervical Cancer (CC), sponsored by University Medical Center Utrecht. Primary endpoint: Serological immune response to HPV-16 and HPV-18. Started Feb 2009; status: active, not recruiting.
02
Drugs
human papillomavirus vaccine
03
Conditions
human papillomavirus infectionCervical Cancer (CC)
Beyond the preview
Go deeper on NL-OMON40068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40068.